Shopping Cart
Remove All
Your shopping cart is currently empty
Hexamethylene bisacetamide inhibits BET Bromodomain Proteins.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $40 | In Stock | In Stock | |
| 100 mg | $55 | In Stock | In Stock | |
| 500 mg | $129 | - | In Stock | |
| 1 g | $193 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | In Stock | In Stock |
| Description | Hexamethylene bisacetamide inhibits BET Bromodomain Proteins. |
| In vitro | As expected of a BET inhibitor, HMBA displaced BET proteins from chromatin, caused massive transcriptional changes, and triggered cell-cycle arrest and apoptosis in Myc-induced B-cell lymphoma cells.?Furthermore, HMBA exerted anticancer effects in vivo in mouse models of Myc-driven B-cell lymphoma[1]. |
| Molecular Weight | 200.28 |
| Formula | C10H20N2O2 |
| Cas No. | 3073-59-4 |
| Smiles | CC(=O)NCCCCCCNC(C)=O |
| Relative Density. | 0.974 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 25 mg/mL (124.83 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9.99 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.